Key result
Rutin administration at 100 mg/kg daily for 60 days significantly reduced plasma glucose levels (134 vs 359 mg/dl, p<0.001) and improved oxidative stress and betatrophin levels in STZ-induced diabetic rats.
Why the study?
Diabetes mellitus is associated with long-term damage and dysfunction of various organs, prompting this study to assess the role of rutin on experimentally induced diabetes.
Does rutin improve biochemical parameters, oxidative stress, and betatrophin levels in STZ-induced diabetic rats?
Does rutin improve biochemical parameters, oxidative stress, and betatrophin levels in STZ-induced diabetic rats?
Absolute Event Rate: 134% vs 359%
p-value: p=<0.001
Rutin exhibits antihyperglycemic and antioxidant activity, and reduces betatrophin levels in a rat model of STZ-induced diabetes.
Rutin should not inform clinical diabetes care; leaves open its antihyperglycemic effects for human translation.
Objective: Diabetes mellitus (DM) is associated with long-term damage, dysfunction, of various organs. Study aims to assessrole of rutin on experimentally induced diabetes. Methods: 50 adult male albino rats divided into 5 groups. Group I (control group, rats were orally administered with 1 ml saline daily). Group II (DMSO group, rats were orally administered with 0.2 % DMSO for 60 d orally). Group III (positive control, animals were injected intraperitoneally with 60 mg/kg b. wtstreptozotocin followed by intraperitoneal injection with 120 mg/kg b. wt of Nicotinamide after 15 min). Group IV (therapeutic group, diabetic rats treated with 100 mg/kg b. wt of rutin for 60 d orally). Group V (standard group, diabetic animals treated with 100 mg/kg b. wt of metformin for 60 d orally). At the end of the experimental period blood serum and plasma, liver, kidney and pancreatic tissues were collected. Results: Diabetic rats showed a significant increase in plasma glucose, serum urea, creatinine, cholesterol and triglyceride. Also, induced oxidative stress as pointed out an increase in MDA level, decrease in GSH level, GST and CAT activities in compared to control group. Also, showed an increase in plasma and tissues levels of betatrophin. Oral administration of rutin cause decrease in elevated biochemical and oxidative stress parameters. Also, decrease betatrophin level when compared with diabetic rats. Our results were confirmed by histopathological examination of different tissues. Conclusion: This study suggests thatrutinexihibitsantihyperglycemic and antioxidant activity in streptozotocin-induced diabetic rats.
No takes yet. Share an insight, caveat, or question.
Abas et al. (2019) studied STZ-induced diabetes mellitus (n=50). Rutin vs. Untreated STZ-induced diabetic rats was evaluated on Plasma glucose (mg/dl) (p=<0.001). Rutin administration at 100 mg/kg daily for 60 days significantly reduced plasma glucose levels (134 vs 359 mg/dl, p<0.001) and improved oxidative stress and betatrophin levels in STZ-induced diabetic rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: